Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesThe application of shock waves in orthopedic and rheumatologic diseases
Modern Rheumatology, 06/19/09
Buch M et al. – Article gives a mini review of the application of shock waves in orthopedics.
- Shock wave therapy (SWT) is used for the 4 main indications:
- Non-union of fractures
- Calcareous tendinitis
- Lateral epicondylitis and
- Plantar faciitis
- SWT is used in non-unions since the early 1990s; rate of success varies between 56 and 90% of bony union
- In pts with calcifications of the rotator cuff, shock wave therapy is used as a last step before operating
- Microfracturing of the deposit and a rupture of the pseudomembrane surrounding the calcification explain this effect
- Disintegration of the deposit can be seen in 73% in 6 wks
- Positive effects in chronic cases of enthesopathies (plantar fasciitis, epicondylitis) are explained by:
- Improvement in blood supply
- Alterations in the neuronal cell membrane and
- Gate control theory
- In chronic cases, when other conservative therapy modalities have failed and pts are sent to surgery, positive results can be achieved in 81% (heel spur) and 69% (epicondylitis)
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Cardiovascular diseases and risk of hip fracture
JAMA, 10/23/09
Update on monthly oral bisphosphonate therapy for the treatment of osteoporosis: focus on ibandronate 150mg and risedronate 150mg
Current Medical Research and Opinion, 10/22/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09
Infliximab treatment in patients with rheumatoid arthritis and spondyloarthropathies in one rheumatological center: two years drug survival
Rheumatology International, 10/14/09
Sponsor
Article Search
Sponsor